Candel Therapeutics at canaccord growth conference: prostate cancer push

Investing.com•Wed, Aug 12, 2026, 04:46 PM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Investing.com](https://www.investing.com/news/transcripts/candel-therapeutics-at-canaccord-growth-conference-prostate-cancer-push-93CH-4855719)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Investing.com ↗

#finance #candel #therapeutics #canaccord #growth #conference #prostate #cancer #push

More Headlines

FinanceSeeking Alpha• 9m ago

908 Devices: Mission Critical Devices Drive Growth

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 10m ago

AMG TimesSquare Mid Cap Growth Fund Q2 2026 Commentary

Developing story — details emerging. Check the source link for the latest updates.

FinanceBloomberg Markets• 12m ago

'Terrific Tail Winds' In Secondaries: Dawn

Nigel Dawn, global head of private capital at Evercore, joins Romaine Bostick on "Bloomberg Deals. " Secondaries deals for private assets surged to a record $121 billion in the first half of 2026, driven by fund managers seeking to hold onto single “trophy” assets longer, according to Evercore.

FinanceInvesting.com• 12m ago

Calix launches scam protection services for broadband providers

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 12m ago

Nike: Full Price Recovery Will Take Time (Downgrade)

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 12m ago

SEC files civil complaint against Netcapital and individuals

Developing story — details emerging. Check the source link for the latest updates.